PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors
Clinical trial NCT03650348 · COMPLETED
Trial details
- NCT number
- NCT03650348
- Sponsor
- Pieris Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-21
- Primary completion
- 2022-08-11
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.